Recombinant bromelain production in Escherichia coli: process optimization in shake flask culture by response surface methodology
© Muntari et al; licensee Springer. 2012
Received: 21 November 2011
Accepted: 15 February 2012
Published: 15 February 2012
Bromelain, a cysteine protease with various therapeutic and industrial applications, was expressed in Escherichia coli, BL21-AI clone, under different cultivation conditions (post-induction temperature, L-arabinose concentration and post-induction period). The optimized conditions by response surface methodology using face centered central composite design were 0.2% (w/v) L-arabinose, 8 hr and 25°C. The analysis of variance coupled with larger value of R2 (0.989) showed that the quadratic model used for the prediction was highly significant (p < 0.05). Under the optimized conditions, the model produced bromelain activity of 9.2 U/mg while validation experiments gave bromelain activity of 9.6 ± 0.02 U/mg at 0.15% (w/v) L-arabinose, 8 hr and 27°C. This study had innovatively developed cultivation conditions for better production of recombinant bromelain in shake flask culture.
Keywordsbromelain Escherichia coli BL21-AI face centered central composite design induction.
The use of highly purified proteins for therapeutic purposes has been in existence for many decades (Paul, 2004). Enzymes, mostly proteases, constitute the largest portion of these purified proteins for industrial and therapeutic applications. Proteases are enzymes that catalyze the hydrolysis of peptide linkages in proteins. They have wide applications in food, pharmaceutical and detergent industries. In fact, these enzymes constitute about 60% of all commercial enzymes in the world (Lucia and Tomas, 2010). Recently, microbial enzymes have been substituting those from other sources and might now account for almost 90% of the total market (Illanes, 2008). This is due to the fact that microbial cells are excellent systems for enzyme production. Thus, there is a great stimulation for extensive research works on recombinant proteins (Illanes, 2008).
Bromelain is a general name given to the family of sulfhydryl proteolytic enzymes (cysteine proteases) obtained from the pineapple plant, Ananas comosus. Depending on the source, it is usually classified as either fruit bromelain or stem bromelain (Kelly 1996). The sulfhydryl proteolytic fraction is the primary component of bromelain. The pineapple enzyme also contains several protease inhibitors, a peroxidase, acid phosphatase, and organically bound calcium (Kelly, 1996).
A member of papain family, stem bromelain (E.C.126.96.36.199) contains 212 amino acid residues including seven cysteines, one of which is involved in catalysis (Bitange et al., 2008). Pure stem bromelain is stable when stored at -20°C and has an optimum pH range of 6-8.5 for most of its substrates (casein, gelatin, synthetic peptides, etc.). The optimum temperature range for the enzyme is 50-60°C. It is mostly activated by cysteine while hydrogen sulfide and sodium cyanide are less effective (Bencucci et al. 2011). However, heavy metals such as mercury and silver, and L-trans-epoxysuccinyl-leucylamido (4-guanidino) butane [also known as E-64] deactivate the enzyme (Maurer, 2001). In contrast, fruit bromelain (E.C. 188.8.131.52) is genetically distinct from stem bromelain. It has higher proteolytic activity and broader specificity for substrates compared to stem bromelain (Maurer, 2001). Bromelain has been widely used in meat tenderization and as a dietary supplement (Ravindra et al. 2008), as well as food processing and baking industry (Lyons, 1982). Bromelain also has greater therapeutic applications. It was firstly introduced as a therapeutic compound in 1957 (Gregory and Kelly, 1996). Clinical applications of bromelain includes modulation of tumor growth, third degree burns, improvement of antibiotic action, etc. (Maurer, 2001).
Response surface methodology (RSM) has been greatly used for the optimization and studying the interactions among various bioprocess parameters using a minimum number of experiments. It is a unit of statistical tools for designing experiments, constructing models, assessing the effects of factors, and exploring optimum conditions of factors under study for desirable responses (de-Coninck et al. 2000). The technique has been widely utilized in many areas of biotechnological processes such as in the production of enzymes and antibiotics (de-Coninck et al. 2000).
Escherichia coli has been continuously utilized for the high-level production of recombinant proteins (Benucci, 2011). This is because of its availability and fully understood genetics. In addition, E. coli has the capacity to grow rapidly at high cell concentrations using cheap media (Manderson et al. 2006). Recombinant proteins expression in E. coli often leads to the formation of insoluble or nonfunctional proteins (Sørensen and Mortensen, 2005). The recovery of soluble protein from the inclusion bodies often yields less active enzyme and can significantly raise the cost of bioseparation (Lilie et al. 1998). Consequently, it is vital to express the protein in a biologically active form. Many factors affecting culture growth rates are being manipulated in order to reduce inclusion bodies formation. These include lowering of culture temperature (Hoffmann and Rinas, 2001), using early induction time of expression (Lim et al. 2000), nutrient and oxygen restriction (Ryan et al. 1989), increasing post-induction time, and regulating the inducer concentration (Manderson et al. 2006).
Considering the significance of assessing the effects of process variables on the recombinant proteins expression, the current research work was geared towards the evaluations of the effects of cultivation conditions (post-induction temperature, inducer concentration and post-induction period) on the production of soluble and active recombinant pineapple stem bromelain in E. coli.
Materials and methods
L-Cysteine, L-arabinose and casein were purchased from Sigma Chemicals Company (USA). Luria Bertani (LB) growth media used was a product of Merck, Germany. All other chemicals used were of analytical grade.
Strain and plasmid
The Escherichia coli BL21-AI strain (Invitrogen, USA) harboring pineapple stem bromelain gene used in this study was described in our earlier study (Amid et al. 2011). Briefly, the gene encoding pineapple stem bromelain was initially cloned into pENTR/TEV/D-TOPO before being sub-cloned into the expression vector pDEST17 (Invitrogen, USA). The expression vector containing recombinant bromelain gene was then transformed in E. coli BL21-AI competent cells.
Screening of cultivation conditions
Induction parameters screened for bromelain production in BL21-AI
Cell concentration (induction time)
OD600 nm of 0.4 - 0.8
0.1 - 0.3% (w/v)
Post-induction period (harvest time)
2 - 10 hr
20 - 37°C
Response surface methodology (RSM)
Experimental design used in RSM studies by using three independent variables for bromelain production
Post induction period, hr
Bromelain production (U/mg)
8.90 ± 0.08
5.00 ± 0.03
4.80 ± 0.02
6.90 ± 0.05
8.70 ± 0.08
9.20 ± 0.09
8.50 ± 0.07
8.50 ± 0.06
9.20 ± 0.09
7.20 ± 0.05
8.90 ± 0.08
8.60 ± 0.06
7.30 ± 0.04
8.90 ± 0.07
7.40 ± 0.05
7.90 ± 0.06
9.20 ± 0.08
8.40 ± 0.05
7.60 ± 0.05
8.80 ± 0.07
where Y is the dependent variable (bromelain production); X1, X2 and X3 are independent variables (temperature, inducer concentration and time, respectively); β0 is an intercept term; β1, β2 and β3 are linear coefficients; β12, β13 and β23 are the interaction coefficients; and β11, β22 and β33 are the quadratic coefficients. The evaluation of the analysis of variance (ANOVA) was determined by conducting the statistical analysis of the model. In order to depict the relationship between the responses and the experimental levels of each of the variables under study, the fitted polynomial equation was expressed in the form of contour and response surface plots.
Validation of the experimental model
The statistical model was validated with respect to the entire three variables within the design space. A set of six experimental combinations, selected as predicted by the point prediction feature of the Design Expert software, were utilized to study the maximum bromelain production under defined conditions. All the experiments were carried out in triplicates and the results were then compared with the predicted values.
Recombinant bromelain production with face centered central composite design (FCCCD)
The effects of varying post-induction temperature, L-arabinose inducer concentration and post-induction period on bromelain production were evaluated in shake flask experiments. As described earlier, all cultures were grown at 37°C and 250 rpm agitation until OD600 nm reaches 0.6. This was followed by adding varying L-arabinose concentrations (0.1-0.3%) to the cultures that were adjusted at different temperatures (20-30°C). The cell cultures were allowed to continue growing for 6 hr, 8 hr and 10 hr (according to the experimental design) after induction and adjustment of growing temperature. Cells were harvested from the spent media by centrifugation (6000×g) at 4°C, for 20 min and stored at -20°C for further use (Ismail and Amid, 2008a; Ismail and Amid, 2008b). All experiments were performed in triplicates.
Enzyme recovery and purification
The harvested cells were subjected to sonication (sonicator, 150 v/t model, Biologics, Inc. USA) on ice using 6-10 sec burst, with 10 sec interval at high amplitude. This was followed by centrifugation (13000×g) at 4°C, for 30 min and the supernatant was collected and purified by AKTA purifier FPLC system (GE Healthcare Bio-Sciences, USA). Purification of recombinant bromelain was conducted in accordance to the manufacturer's instructions. A glass column for chromatography (4.6 mm × 100 mm, Life Technologies, California) was filled with 1 mL of Ni-NTA His•Bind resin (Novagen, Germany). The FPLC system was set at flow rate of 1 mL/min. Washing step was achieved by using wash buffer (50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH 8) while purified recombinant bromelain was eluted using elution buffer (50 mM NaH2PO4, 300 mM NaCl, 500 mM imidazole, pH 8).
After each step of enzyme recovery and purification, the protein fractions were tested by SDS-PAGE in 12.5% polyacrylamide gels as described earlier (Amid et al. 2011). Visualization was conducted by staining with Coomassie Brilliant blue (Laemmli, 1970).
Determination of enzyme activity
The reaction mixture contained 0.1 mL of purified recombinant bromelain and 1.1 mL of 1% casein in 0.1 M Tris-HCl buffer (pH 8.0) with 20 mM cysteine (final concentration). The reaction was conducted at 37°C for 20 min. The reaction was stopped by adding 1.8 mL of 5% (w/v) trichloroacetic acid (TCA). This was followed by centrifugation at 10000×g for 15 min and the absorbance of the supernatant was measured at 280 nm. One unit (U) of the enzyme was defined as the amount of protease that produces an increment of one absorbance unit per minute in the assay conditions (Bruno et al. 2003).
Screening of culture growth induction conditions using one-factor-at-a-time (OFAT) method
In order to explore the possibility of improving the expression level of recombinant bromelain, several one-factor experiments were employed to investigate the effects of various cultivation conditions on recombinant bromelain production. The tested variables included cell concentration, post-induction temperature, inducer concentration and post-induction period for cell harvest. All the experiments were carried out in triplicates.
Cell concentration (induction time)
Effects of L-arabinose concentration
Post-induction period for cell harvest
Optimization by Response Surface Methodology (RSM)
where the response (Y) is the bromelain production, while A, B and C are the temperature, inducer concentration and post-induction period, respectively.
Analysis of Variance of quadratic model for bromelain production
Sum of squares
Post-induction temperature, A
Inducer concentration, B
Post-induction period, C
Lack of fit
Moreover, Figure 5b represents the 3D plot corresponding to temperature and post-induction period. The plot exhibited an elliptical contour that suggests both optimum operating conditions and the interaction effects between the two factors are significant. Figure 5b shows that maximum bromelain production was attained at 8 hr post-induction period.
Similarly, in the case of inducer concentration and post induction time (Figure 5c); the response plot was elliptical signifying interaction between them with optimum production of the enzyme. Consequently, the optimized cultivation conditions synergistically favor higher production of bromelain.
Experimental model validation
Inducer concentration (% w/v)
Post induction period
9.60 ± 0.02
9.30 ± 0.03
8.90 ± 0.03
9.10 ± 0.02
9.20 ± 0.03
9.30 ± 0.03
There are several strategies that are being employed to improve culture cultivation conditions for expressing soluble recombinant proteins in E. coli. The screening of experimental conditions for the improvement of enzyme expression coupled with the RSM experimental design serve as vital tool for analyzing the influence of cultivation conditions on the expression of recombinant bromelain. The design had proved to be effective in determining the important induction conditions that have significant effect on recombinant bromelain production in E. coli BL21-AI. Using face centered central composite design (FCCCD), the optimum induction conditions for high bromelain activity were induction temperature (27°C), L-arabinose concentration (0.15% w/v) and post-induction period of 8 hr. The results presented in this research for the analysis of cultivation conditions for the expression of recombinant bromelain corroborate the applicability of experimental design to the field of molecular biology.
This study had found out that the studied parameters had exerted great effects on the production of recombinant bromelain at higher level. Lower cultivation temperature of 25°C under optimized conditions (Figure 5a and 5b), had effectively improved the bromelain production. It is an established fact that expression of soluble recombinant enzymes is highly favored by lower growth temperature. During expression of recombinant proteins that have tendency to form insoluble aggregates in E. coli, decreasing the post-induction temperature has been shown to significantly reduce protein aggregation (MacDonald et al. 2003). In addition, in T7 expression system (used in this study), a large number of recombinant proteins often precipitate when expressed at 37°C, but tend to be soluble when induction temperature is lowered to 15-25°C (Vera et al. 2007). This is because slower rates of protein production allow the newly transcribed recombinant proteins sufficient time to fold properly. Hence, lower temperatures during induction in such expression system should be used as the default (Vera et al. 2007). This is also supported by the findings of Schein and Noteborn (1988) in which the productions of soluble fraction of the recombinant proteins expressed in various E. coli strains were increased at culture temperatures in the range of 20-30°C.
Moreover, temperature also affects the stability of plasmid in recombinant E. coli cultures (Shin et al. 1997 & Wang et al. 2005) and thus affects production of soluble proteins (Islam et al. 2007 & Swalley et al. 2006). Lower temperatures coupled with lower cell growth rates usually favor higher production of soluble protein. This is based on the type of expression system and recombinant protein involved (Urban et al. 2003). The results from the aforementioned study (Urban et al. 2003) are in well accordance with our findings.
In this study, it was discovered that moderate concentration of L-arabinose (0.2% w/v) used under the optimized conditions, has greatly contributed towards attaining higher bromelain production as shown in Figure 3, 5a and 5c. This indicated that higher levels of L-arabinose decreases recombinant protein expression. In fact it has been reported that higher concentrations of L-arabinose cause over production of recombinant protein that leads to ribosomal destruction, production of heat shock proteins and eventually cell death (Guzman et al. 1995). Our findings are consistent with the works of Manderson et al. (2006) in which maximum recombinant aspin production was attained at L-arabinose concentration of 0.2%(w/v) but reduced at higher inducer concentration. Aspin is an aspartyl protease inhibitor homolog which is being produced by the parasitic nematode, Trichostrongylus colubriformis (Manderson et al. 2006). In addition, the use of partial induction to slow the rate of recombinant protein expression has been reported to enhance the formation of soluble protein (Lim et al. 2000). More so, a significant increase was observed in the production of soluble interferon upon induction with low level of L-arabinose (Lim et al. 2000).
The optimization studies in this work were conducted at a fixed cell concentration (induction time) which was screened earlier under OFAT method. Maximum bromelain production was achieved at cell concentration of OD600 nm = 0.6 as shown in Figure 1. The effects of induction time depend on the specific expression case (Manderson et al. 2006). In some cases, early induction increases soluble protein production of some recombinant proteins by limiting the culture growth rate (Delisa et al. 2001). This was supported by the findings of Lim and Jung (1998) in which a five-fold improvement in soluble interferon production was attained by induction in early logarithmic phase. However, Akesson et al. (2001) had reported higher levels of recombinant protein expression when induced in the late exponential growth phase.
The effect of post-induction period on bromelain production was found to be at its peak after 8 hr as shown in Figure 4, 5b and 5c. Bromelain production started to reduce beyond this period. Thus, cultivation at lower temperatures and moderately longer post-induction period could significantly enhance the expression of the recombinant protein in comparison with the standard E. coli growth temperature of 37°C. This could be explained by the fact that the solubility and refolded conformation of recombinant enzymes were greatly enhanced by cultivation conditions and certain post-translational time was needed to get a mature protein with high enzymatic activity (Xu et al. 2007). It is vital to control the time and extent of plasmid gene expression as the recombinant protein can effectively inhibit host cell growth, presumably due to its toxicity (Shin et al. 1997). Moreover, the metabolic load exerted on the host cells through heterologous gene expression may lead to retardation of growth (Manderson et al. 2006).
All the tests were carried out at 37°C, OD600 nm of 0.4, 0.2% (w/v) L-arabinose and 4 hr post-induction period (besides the specific tested conditions).
Cultivation conditions and their ranges were selected based on literature reports on recombinant proteins expression.
The authors are most grateful to the Department of Biotechnology Engineering, IIUM, for providing all the required laboratory facilities to successfully conduct the research work as well as financial assistance from the Ministry of Higher Education, Malaysia (FRGS grant no.11-04-0162) to Azura Amid and Hamzah M. Salleh.
- Akesson M, Hagander P, Axelsson J: Avoiding acetate accumulation in Escherichia coli cultures using feedback control of glucose feeding. Biotechnol Bioeng 2001, 73: 223–30. 10.1002/bit.1054View ArticlePubMedGoogle Scholar
- Amid A, Ismail N, Yusof F, Salleh HM: Expression, purification and characterization of a recombinant stem bromelain from Ananas comosus . Process Biochem 2011, 46: 2232–2239. 10.1016/j.procbio.2011.08.018View ArticleGoogle Scholar
- Bencucci I, Liburdi K, Garzillo A, Maria V, Esti M: Bromelain from pineapple stem in alcoholic-acid buffers for wine application. Food Chem 2011,124(4):1349–1353. 10.1016/j.foodchem.2010.07.087View ArticleGoogle Scholar
- Bitange NT, Zhang W, Ying X, Wenbin Z: Therapeutic application of pineapple protease (bromelain): A review. Pakst J of Nutr 2008,7(4):513–520. 10.3923/pjn.2008.513.520View ArticleGoogle Scholar
- Bruno MA, Pardo MF, Caffini NO, Lo'pez LMI: Hieronymain I, a new cysteine peptidase isolated from unripe fruits of Bromelia hieronymi Mez (Bromeliaceae). J Protein Chem 2003, 22: 127–134. 10.1023/A:1023418812832View ArticlePubMedGoogle Scholar
- de Coninck J, Bouquelet S, Dumortier V, Duy F, Verdier-Denantes I: Industrial media and fermentation processes for improved growth and protease production by Tetrahymena thermophila. J Ind Microbiol Biotech 2000, 24: 285–290. 10.1038/sj.jim.2900826View ArticleGoogle Scholar
- DeLisa MP, Chae HJ, Weigand WA, Valdes JJ, Rao G, Bentley WE: Generic model control of induced protein expression in high cell density cultivation of Escherichia coli using on-line GFP-fusion monitoring. Bioproc Biosys Eng 2001, 24: 83–91. 10.1007/s004490100229View ArticleGoogle Scholar
- Guzman LM, Belin D, Carson MJ, Beckwith J: Tight regulation, modulation, and high-level expression by vectors containing the arabinose P BAD promoter. J Bacteriol 1995, 177: 4121–30.PubMed CentralPubMedGoogle Scholar
- Haaland PD: Separating signals from the noise. In Experimental design in biotechnology. Marcel Dekker, New York; 1989.Google Scholar
- Hoffmann F, Rinas U: Plasmid amplification in Escherichia coli after temperature up shift is impaired by induction of recombinant protein synthesis. Biotechnol Lett 2001, 23: 1819–25. 10.1023/A:1012718200638View ArticleGoogle Scholar
- Illanes A: Enzyme Biocatalysis: Principle and application. Springer Science and Business Media, Brazil 2008.Google Scholar
- Islam RS, Tisi D, Levy MS, Lye GJ: Framework for the rapid optimization of soluble protein expression in Escherichia coli combining microscale experiments and statistical experimental design. Biotechnol Prog 2007, 23: 785–793.View ArticlePubMedGoogle Scholar
- Ismail N, Amid A: Fast and reliable cloning method for bromelain gene from pineapple ( Ananas comosus ) stem. Abstract of International Conference on Science & Technology: Applications in Industry & Education, Kuala Lumpur 2008.Google Scholar
- Ismail N, Amid A: Molecular cloning, insertion and transcription confirmation and expression study of bromelain gene from Ananas comosus . Abstract of the Conference on International Graduate on Engineering and Science (IGCES'08), Kuala Lumpur 2008.Google Scholar
- Kelly GS: Bromelain: A literature review and discussion of its therapeutic applications. Alt Med Rev 1996,1(4):243–257.Google Scholar
- Laemmli U: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 237: 680–685.View ArticleGoogle Scholar
- Lilie H, Schwarz E, Rudolph R: Advances in refolding of proteins produced in E. coli . Curr Opin Biotechnol 1998, 9: 497–501. 10.1016/S0958-1669(98)80035-9View ArticlePubMedGoogle Scholar
- Lim HK, Jung KH: Improvement of heterologous protein productivity Escherichia coli under control of the P L promoter. Biotechnol Prog 1998, 14: 548–53. 10.1021/bp980059yView ArticlePubMedGoogle Scholar
- Lim HK, Jung KH, Park DH, Chung SI: Production characteristics of interferon-a using an l-arabinose promoter system in a high-cell-density culture. Appl Microbiol Biotechnol 2000, 53: 201–28. 10.1007/s002530050009View ArticlePubMedGoogle Scholar
- Lucia F, Tomas GV: Native and Biotechnologically engineered Plant Proteases with Industrial applications. J Food Bioprocess Technol 2010, 4: 1066–1088.Google Scholar
- Lyons TP: Proteinase enzymes relevant to the baking industry. Biochemical Society Transactions 1982,10(4):287–290.View ArticlePubMedGoogle Scholar
- Maurer HR: Bromelain: Biochemistry, Pharmacology and Medical Uses. Cell Mol life Sci 2001, 58: 1234–1245. 10.1007/PL00000936View ArticlePubMedGoogle Scholar
- Manderson D, Dempster R, Chisti Y: Production of an active recombinant Aspin antigen in Escherichia coli for identifying animals resistant to nematode infection. Enzyme and Microbial Technol 2006, 38: 591–598. 10.1016/j.enzmictec.2005.03.029View ArticleGoogle Scholar
- MacDonald LM, Armson A, Thompson RCA, Reynoldson JA: Characterization of factors favoring the expression of soluble protozoan tubulin proteins in Escherichia coli . Protein Express Pur 2003, 29: 117–22. 10.1016/S1046-5928(03)00006-8View ArticleGoogle Scholar
- Paul C: Protein purification Protocols. Human press, Totowa, New Jersey; 2004.Google Scholar
- Ravindra BB, Rastogi NK, Raghavarao KS: Liquid-liquid extraction of bromelain and polyphenol oxidase using aqueous two-phase system. Chem Engin Process 2008, 47: 83–89. 10.1016/j.cep.2007.08.006View ArticleGoogle Scholar
- Ryan W, Parulekar SJ, Stark BC: Expression of B-lactamase by recombinant Escherichia coli strains containing plasmids of different sizes-effect of pH, phosphate, dissolved oxygen. Biotechnol Bioeng 1989, 34: 309–331. 10.1002/bit.260340306View ArticlePubMedGoogle Scholar
- Salihu A, Alam MZ, AbdulKarim MI, Salleh MH: Optimization of lipase production by Candida cylindracea in palm oil mill effluent based medium using statistical experimental design. Journal of Molecular Catalysis B: Enzymatic 2011, 69: 66–73. 10.1016/j.molcatb.2010.12.012View ArticleGoogle Scholar
- Schein CH, Noteborn MHM: Formation of soluble recombinant proteins in Escherichia coli is favoured by lower growth temperature. Biotechnol 1988, 6: 291–4. 10.1038/nbt0388-291View ArticleGoogle Scholar
- Shin CS, Hong MS, Bae CS, Lee J: Enhanced production of human mini proinsulin in fed-batch cultures at high cell density of Escherichia coli BL21(DE3)[pET-3aT2M2]. Biotechnol Prog 1997, 13: 249–257. 10.1021/bp970018mView ArticlePubMedGoogle Scholar
- Sørensen HP, Mortensen KK: Soluble expression of recombinant proteins in the cytoplasm of Escherichia coli . Microbial Cell Factories 2005,4(1):1–8. 10.1186/1475-2859-4-1PubMed CentralView ArticlePubMedGoogle Scholar
- Swalley SE, Fulghum JR, Chambers SP: Screening factors effecting a response in soluble protein expression: formalized approach using design of experiments. Anal Biochem 2006, 351: 122–127. 10.1016/j.ab.2005.11.046View ArticlePubMedGoogle Scholar
- Urban A, Ansmant I, Motorin Y: Optimisation of expression and purification of the recombinant Yol066 (Rib2) protein from Saccharomyces cerevisiae. J Chromatogr B 2003, 786: 187–195. 10.1016/S1570-0232(02)00742-0View ArticleGoogle Scholar
- Vera A, Gonzalez-Montalban N, Aris A, Villaverde A: The conformational quality of insoluble recombinant proteins is enhanced at low growth temperatures. Biotechnol Bioeng 2007, 96: 1101–1106. 10.1002/bit.21218View ArticlePubMedGoogle Scholar
- Wang Y, Jing C, Yang B, Mainda G, Dong M, Xu A: Production of a new sea anemone neurotoxin by recombinant Escherichia coli : optimization of culture conditions using response surface methodology. Process Biochem 2005, 40: 2721–2728. 10.1016/j.procbio.2004.12.024View ArticleGoogle Scholar
- Xu Z, Jing K, Liu Y, Cen P: High-level expression of recombinant glucose dehydrogenase and its application in NADPH regeneration. J Ind Microbiol Biotechnol 2007, 34: 83–90.View ArticlePubMedGoogle Scholar
- Xu Z, Zhong Z, Huang L, Peng L, Wang F, Cen P: sHigh-level production of bioactive human beta-defensin-4 in Escherichia coli by soluble fusion expression. Appl Microbiol Biotechnol 2006, 72: 471–479. 10.1007/s00253-005-0287-0View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.